Policy Cures Research: Amidst COVID-19, Disease X looms and more cross-cutting R&D funds needed for all emerging infectious diseases, says new G-FINDER report
“Emerging infectious diseases — both known and unknown — remain a constant threat as the world fights COVID-19, yet past R&D investments show the need for more consistent and diversified funding to prevent future pandemics, according to the new G-FINDER report on emerging infectious disease (EID) by Policy Cures Research, a global health think tank. The report, Landscape of Emerging Infectious Disease R&D: Preventing the next pandemic, tracks global funding for basic research and products such as vaccines, therapeutics, and diagnostics to fight priority EIDs, including coronaviruses, Ebola, and Zika, as well as Disease X — the name given to unknown pathogens with pandemic potential — between 2014 and 2018…” (9/17).